- Home
- WELL vs MDT Comparison
WELL vs MDT Comparison
Compare WELL & MDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WELL
- MDT
- Stock Information
- Founded
- WELL 1970
- MDT 1949
- Country
- WELL United States
- MDT Ireland
- Employees
- WELL N/A
- MDT N/A
- Industry
- WELL Real Estate Investment Trusts
- MDT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- WELL Real Estate
- MDT Health Care
- Exchange
- WELL Nasdaq
- MDT Nasdaq
- Market Cap
- WELL 98.7B
- MDT 112.1B
- IPO Year
- WELL N/A
- MDT N/A
- Fundamental
- Price
- WELL $151.27
- MDT $86.34
- Analyst Decision
- WELL Buy
- MDT Buy
- Analyst Count
- WELL 11
- MDT 15
- Target Price
- WELL $159.64
- MDT $98.00
- AVG Volume (30 Days)
- WELL 2.8M
- MDT 8.3M
- Earning Date
- WELL 07-28-2025
- MDT 05-21-2025
- Dividend Yield
- WELL 1.77%
- MDT 3.29%
- EPS Growth
- WELL 111.52
- MDT 30.80
- EPS
- WELL 1.73
- MDT 3.61
- Revenue
- WELL $8,554,464,000.00
- MDT $33,537,000,000.00
- Revenue This Year
- WELL $26.15
- MDT $6.31
- Revenue Next Year
- WELL $12.12
- MDT $5.27
- P/E Ratio
- WELL $87.53
- MDT $23.88
- Revenue Growth
- WELL 24.49
- MDT 3.62
- 52 Week Low
- WELL $100.13
- MDT $75.96
- 52 Week High
- WELL $158.55
- MDT $96.25
- Technical
- Relative Strength Index (RSI)
- WELL 50.51
- MDT 52.60
- Support Level
- WELL $149.70
- MDT $85.41
- Resistance Level
- WELL $154.13
- MDT $88.77
- Average True Range (ATR)
- WELL 2.93
- MDT 1.28
- MACD
- WELL -0.17
- MDT 0.01
- Stochastic Oscillator
- WELL 37.61
- MDT 62.96
About WELL Welltower Inc.
Welltower owns a diversified healthcare portfolio of 2,336 in-place properties spread across the senior housing, medical office, and skilled nursing/postacute care sectors. The portfolio includes over 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to that of the United States.
About MDT Medtronic plc.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.